Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2025 ASCO Annual Meeting
2025 ASBrS Annual Meeting
ESTRO 2025
DDW 2025
2025 AACR Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2023+ASTRO+Annual+Meeting
«
1
»
Advertisement
Advertisement
Jun
13
Today In Oncology
FDA Approves Mitomycin Intravesical Solution for Recurrent Low-Grade Intermediate-Risk Non–Muscle-Invasive Bladder Cancer
FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer
CancerCare Survey Reveals How Insurance Red Tape Impacts Cancer Treatment Delays
Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer
Elinzanetant for Vasomotor Symptoms From Endocrine Therapy for Breast Cancer
View More
Advertisement
